Literature DB >> 27401738

Prominent QTc prolongation in a patient with a rare variant in the cardiac ryanodine receptor gene.

Yuki Taniguchi1,2, Aya Miyazaki3, Heima Sakaguchi1, Yousuke Hayama1, Norihiro Ebishima1, Jun Negishi1, Kanae Noritake1, Yoshihiro Miyamoto4, Wataru Shimizu5,6, Takeshi Aiba5, Hideo Ohuchi1.   

Abstract

We report the case of a 12-year-old female patient with a history of four syncopal episodes related to exercise over 2 years and who showed prominent QTc prolongation on electrocardiogram; therefore, she was clinically diagnosed with long QT syndrome type-1. However, genetic analysis did not identify any LQT-related genes but showed a rare missense variant in the cardiac ryanodine receptor gene. From the results of drug-loading tests, administration of oral propranolol was initiated; thereafter, she experienced no syncopal episodes. This is a case report demonstrating the "overlapping clinical features" of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia.

Entities:  

Keywords:  Catecholaminergic polymorphic ventricular tachycardia; Long QT syndrome; Premature ventricular conduction; Ryanodine receptor 2 gene

Mesh:

Substances:

Year:  2016        PMID: 27401738     DOI: 10.1007/s00380-016-0869-z

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  13 in total

1.  A novel mutation in the cardiac ryanodine receptor gene (RyR2) in a patient with an unequivocal LQTS.

Authors:  Silke Kauferstein; Nadine Kiehne; Damir Erkapic; Jörn Schmidt; Christian W Hamm; Hansjürgen Bratzke; Heinz-Friedrich Pitschner; Malte Kuniss; Thomas Neumann
Journal:  Int J Cardiol       Date:  2010-12-03       Impact factor: 4.164

Review 2.  HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.

Authors:  Silvia G Priori; Arthur A Wilde; Minoru Horie; Yongkeun Cho; Elijah R Behr; Charles Berul; Nico Blom; Josep Brugada; Chern-En Chiang; Heikki Huikuri; Prince Kannankeril; Andrew Krahn; Antoine Leenhardt; Arthur Moss; Peter J Schwartz; Wataru Shimizu; Gordon Tomaselli; Cynthia Tracy
Journal:  Heart Rhythm       Date:  2013-08-30       Impact factor: 6.343

3.  Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing.

Authors:  David J Tester; Laura J Kopplin; Melissa L Will; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2005-10       Impact factor: 6.343

Review 4.  Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects.

Authors:  Masa-aki Kawashiri; Kenshi Hayashi; Tetsuo Konno; Noboru Fujino; Hidekazu Ino; Masakazu Yamagishi
Journal:  Heart Vessels       Date:  2013-08-02       Impact factor: 2.037

5.  Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome.

Authors:  Wataru Shimizu; Takashi Noda; Hiroshi Takaki; Noritoshi Nagaya; Kazuhiro Satomi; Takashi Kurita; Kazuhiro Suyama; Naohiko Aihara; Kenji Sunagawa; Shigeyuki Echigo; Yoshihiro Miyamoto; Yasunao Yoshimasa; Kazufumi Nakamura; Tohru Ohe; Jeffrey A Towbin; Silvia G Priori; Shiro Kamakura
Journal:  Heart Rhythm       Date:  2004-09       Impact factor: 6.343

6.  The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.

Authors:  Argelia Medeiros-Domingo; Zahurul A Bhuiyan; David J Tester; Nynke Hofman; Hennie Bikker; J Peter van Tintelen; Marcel M A M Mannens; Arthur A M Wilde; Michael J Ackerman
Journal:  J Am Coll Cardiol       Date:  2009-11-24       Impact factor: 24.094

7.  Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes.

Authors:  Grace Choi; Laura J Kopplin; David J Tester; Melissa L Will; Carla M Haglund; Michael J Ackerman
Journal:  Circulation       Date:  2004-10-04       Impact factor: 29.690

8.  Phenotype variability in patients carrying KCNJ2 mutations.

Authors:  Hiromi Kimura; Jun Zhou; Mihoko Kawamura; Hideki Itoh; Yuka Mizusawa; Wei-Guang Ding; Jie Wu; Seiko Ohno; Takeru Makiyama; Akashi Miyamoto; Nobu Naiki; Qi Wang; Yu Xie; Tsugutoshi Suzuki; Shigeru Tateno; Yoshihide Nakamura; Wei-Jin Zang; Makoto Ito; Hiroshi Matsuura; Minoru Horie
Journal:  Circ Cardiovasc Genet       Date:  2012-05-15

9.  Exome Analyses of Long QT Syndrome Reveal Candidate Pathogenic Mutations in Calmodulin-Interacting Genes.

Authors:  Daichi Shigemizu; Takeshi Aiba; Hidewaki Nakagawa; Kouichi Ozaki; Fuyuki Miya; Wataru Satake; Tatsushi Toda; Yoshihiro Miyamoto; Akihiro Fujimoto; Yutaka Suzuki; Michiaki Kubo; Tatsuhiko Tsunoda; Wataru Shimizu; Toshihiro Tanaka
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

10.  Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.

Authors:  Silvia G Priori; Carlo Napolitano; Mirella Memmi; Barbara Colombi; Fabrizio Drago; Maurizio Gasparini; Luciano DeSimone; Fernando Coltorti; Raffaella Bloise; Roberto Keegan; Fernando E S Cruz Filho; Gabriele Vignati; Abraham Benatar; Angelica DeLogu
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

View more
  2 in total

1.  Bradycardia Is a Specific Phenotype of Catecholaminergic Polymorphic Ventricular Tachycardia Induced by RYR2 Mutations.

Authors:  Kazuaki Miyata; Seiko Ohno; Hideki Itoh; Minoru Horie
Journal:  Intern Med       Date:  2018-02-09       Impact factor: 1.271

Review 2.  Clinical Genetics of Inherited Arrhythmogenic Disease in the Pediatric Population.

Authors:  Estefanía Martínez-Barrios; Sergi Cesar; José Cruzalegui; Clara Hernandez; Elena Arbelo; Victoria Fiol; Josep Brugada; Ramon Brugada; Oscar Campuzano; Georgia Sarquella-Brugada
Journal:  Biomedicines       Date:  2022-01-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.